(KRP) Kimbell Royalty Partners - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US49435R1023
Stock: Mineral, Royalty, Oil, Gas, Interests
Total Rating 50
Risk 41
Buy Signal -0.44
| Risk 5d forecast | |
|---|---|
| Volatility | 20.3% |
| Relative Tail Risk | 5.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 5.34 |
| Character TTM | |
|---|---|
| Beta | 0.687 |
| Beta Downside | 0.864 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.58% |
| CAGR/Max DD | 0.34 |
EPS (Earnings per Share)
Revenue
Description: KRP Kimbell Royalty Partners March 03, 2026
Kimbell Royalty Partners, LP (NYSE: KRP) is a Texas-based royalty and mineral interest holder that acquires and manages oil and natural-gas assets across the United States. Founded in 1998, the firm generates cash flow primarily through royalty streams rather than operating costs, positioning it as a pure-play exposure to upstream price movements.
As of the latest quarterly report (Q4 2023), KRP produced roughly 70,000 barrels of oil equivalent per day, delivering net cash flow of $210 million and sustaining a dividend yield near 5.5%. The company’s cash-on-cash return remains above 12%, and its debt-to-EBITDA ratio is under 2.0x, reflecting a strong balance sheet. Key economic drivers include the rebound in U.S. natural-gas prices after the 2023 winter demand spike and ongoing OPEC-plus production cuts that support crude-oil benchmarks, both of which boost royalty revenues.
For a deeper dive, you might explore ValueRay’s analytical tools.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 56.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -20.53 > 1.0 |
| NWC/Revenue: 23.44% < 20% (prev 23.34%; Δ 0.09% < -1%) |
| CFO/TA 0.20 > 3% & CFO 246.5m > Net Income 56.0m |
| Net Debt (401.9m) to EBITDA (226.1m): 1.78 < 3 |
| Current Ratio: 8.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.1m) vs 12m ago 1.57% < -2% |
| Gross Margin: 93.88% > 18% (prev 0.50%; Δ 9338 % > 0.5%) |
| Asset Turnover: 28.42% > 50% (prev 27.74%; Δ 0.68% > 0%) |
| Interest Coverage Ratio: 3.85 > 6 (EBITDA TTM 226.1m / Interest Expense TTM 34.5m) |
Altman Z''
| A: 0.06 (Total Current Assets 88.5m - Total Current Liabilities 10.2m) / Total Assets 1.23b |
| B: error (Retained Earnings missing) |
| C: 0.11 (EBIT TTM 132.8m / Avg Total Assets 1.17b) |
| D: 1.17 (Book Value of Equity 531.8m / Total Liabilities 456.2m) |
Beneish M
| DSRI: none (Receivables none/48.7m, Revenue 333.8m/310.7m) |
| GMI: 0.53 (GM 93.88% / 49.93%) |
| AQI: 177.5 (AQ_t 0.92 / AQ_t-1 0.01) |
| SGI: 1.07 (Revenue 333.8m / 310.7m) |
| TATA: -0.15 (NI 56.0m - CFO 246.5m) / TA 1.23b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of KRP shares?
As of March 07, 2026, the stock is trading at USD 14.40 with a total of 896,397 shares traded.
Over the past week, the price has changed by +0.42%, over one month by +4.42%, over three months by +13.30% and over the past year by +21.17%.
Over the past week, the price has changed by +0.42%, over one month by +4.42%, over three months by +13.30% and over the past year by +21.17%.
Is KRP a buy, sell or hold?
Kimbell Royalty Partners has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy KRP.
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KRP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16 | 11.1% |
| Analysts Target Price | 16 | 11.1% |
KRP Fundamental Data Overview March 02, 2026
P/E Forward = 9.1158
P/S = 4.6344
P/B = 1.9123
Revenue TTM = 333.8m USD
EBIT TTM = 132.8m USD
EBITDA TTM = 226.1m USD
Long Term Debt = 448.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 445.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 401.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.95b USD (1.55b + Debt 445.9m - CCE 44.0m)
Interest Coverage Ratio = 3.85 (Ebit TTM 132.8m / Interest Expense TTM 34.5m)
EV/FCF = 85.54x (Enterprise Value 1.95b / FCF TTM 22.8m)
FCF Yield = 1.17% (FCF TTM 22.8m / Enterprise Value 1.95b)
FCF Margin = 6.83% (FCF TTM 22.8m / Revenue TTM 333.8m)
Net Margin = 16.79% (Net Income TTM 56.0m / Revenue TTM 333.8m)
Gross Margin = 93.88% ((Revenue TTM 333.8m - Cost of Revenue TTM 20.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev 93.04%)
Tobins Q-Ratio = 1.59 (Enterprise Value 1.95b / Total Assets 1.23b)
Interest Expense / Debt = 2.05% (Interest Expense 9.12m / Debt 445.9m)
Taxrate = 43.02% (42.3m / 98.3m)
NOPAT = 75.7m (EBIT 132.8m * (1 - 43.02%))
Current Ratio = 8.64 (Total Current Assets 88.5m / Total Current Liabilities 10.2m)
Debt / Equity = 0.84 (Debt 445.9m / totalStockholderEquity, last quarter 531.8m)
Debt / EBITDA = 1.78 (Net Debt 401.9m / EBITDA 226.1m)
Debt / FCF = 17.64 (Net Debt 401.9m / FCF TTM 22.8m)
Total Stockholder Equity = 714.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.77% (Net Income 56.0m / Total Assets 1.23b)
RoE = 7.84% (Net Income TTM 56.0m / Total Stockholder Equity 714.6m)
RoCE = 11.42% (EBIT 132.8m / Capital Employed (Equity 714.6m + L.T.Debt 448.5m))
RoIC = 6.42% (NOPAT 75.7m / Invested Capital 1.18b)
WACC = 6.82% (E(1.55b)/V(1.99b) * Re(8.45%) + D(445.9m)/V(1.99b) * Rd(2.05%) * (1-Tc(0.43)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.14%
[DCF] Terminal Value 75.93% ; FCFF base≈114.0m ; Y1≈74.8m ; Y5≈34.1m
[DCF] Fair Price = 4.78 (EV 848.4m - Net Debt 401.9m = Equity 446.4m / Shares 93.4m; r=6.82% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -36.79 | EPS CAGR: 14.09% | SUE: 0.74 | # QB: 0
Revenue Correlation: 51.21 | Revenue CAGR: 4.09% | SUE: 1.13 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=-0.013 | Chg30d=-0.003 | Revisions Net=+2 | Analysts=1
EPS current Year (2026-12-31): EPS=0.56 | Chg7d=-0.077 | Chg30d=-0.010 | Revisions Net=+2 | Growth EPS=-21.8% | Growth Revenue=-3.5%
EPS next Year (2027-12-31): EPS=0.66 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=+1 | Growth EPS=+17.9% | Growth Revenue=+6.1%
P/S = 4.6344
P/B = 1.9123
Revenue TTM = 333.8m USD
EBIT TTM = 132.8m USD
EBITDA TTM = 226.1m USD
Long Term Debt = 448.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 445.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 401.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.95b USD (1.55b + Debt 445.9m - CCE 44.0m)
Interest Coverage Ratio = 3.85 (Ebit TTM 132.8m / Interest Expense TTM 34.5m)
EV/FCF = 85.54x (Enterprise Value 1.95b / FCF TTM 22.8m)
FCF Yield = 1.17% (FCF TTM 22.8m / Enterprise Value 1.95b)
FCF Margin = 6.83% (FCF TTM 22.8m / Revenue TTM 333.8m)
Net Margin = 16.79% (Net Income TTM 56.0m / Revenue TTM 333.8m)
Gross Margin = 93.88% ((Revenue TTM 333.8m - Cost of Revenue TTM 20.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev 93.04%)
Tobins Q-Ratio = 1.59 (Enterprise Value 1.95b / Total Assets 1.23b)
Interest Expense / Debt = 2.05% (Interest Expense 9.12m / Debt 445.9m)
Taxrate = 43.02% (42.3m / 98.3m)
NOPAT = 75.7m (EBIT 132.8m * (1 - 43.02%))
Current Ratio = 8.64 (Total Current Assets 88.5m / Total Current Liabilities 10.2m)
Debt / Equity = 0.84 (Debt 445.9m / totalStockholderEquity, last quarter 531.8m)
Debt / EBITDA = 1.78 (Net Debt 401.9m / EBITDA 226.1m)
Debt / FCF = 17.64 (Net Debt 401.9m / FCF TTM 22.8m)
Total Stockholder Equity = 714.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.77% (Net Income 56.0m / Total Assets 1.23b)
RoE = 7.84% (Net Income TTM 56.0m / Total Stockholder Equity 714.6m)
RoCE = 11.42% (EBIT 132.8m / Capital Employed (Equity 714.6m + L.T.Debt 448.5m))
RoIC = 6.42% (NOPAT 75.7m / Invested Capital 1.18b)
WACC = 6.82% (E(1.55b)/V(1.99b) * Re(8.45%) + D(445.9m)/V(1.99b) * Rd(2.05%) * (1-Tc(0.43)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.14%
[DCF] Terminal Value 75.93% ; FCFF base≈114.0m ; Y1≈74.8m ; Y5≈34.1m
[DCF] Fair Price = 4.78 (EV 848.4m - Net Debt 401.9m = Equity 446.4m / Shares 93.4m; r=6.82% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -36.79 | EPS CAGR: 14.09% | SUE: 0.74 | # QB: 0
Revenue Correlation: 51.21 | Revenue CAGR: 4.09% | SUE: 1.13 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=-0.013 | Chg30d=-0.003 | Revisions Net=+2 | Analysts=1
EPS current Year (2026-12-31): EPS=0.56 | Chg7d=-0.077 | Chg30d=-0.010 | Revisions Net=+2 | Growth EPS=-21.8% | Growth Revenue=-3.5%
EPS next Year (2027-12-31): EPS=0.66 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=+1 | Growth EPS=+17.9% | Growth Revenue=+6.1%